1Sherman ME, Bitterman P, Rosenshein NB, et al. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol, 1992,16 (6) :600- 610.
2Ambros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol, 1995,26( 11 ) : 1260-1267.
3Spiegel GW. Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol, 1995,19(4) :417-432.
4Zheng W, Khurana R, Farahmand S, et al. p.53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol, 1998,22( 12 ) : 1463-1473.
5Carcangiu ML, Tan LK, Chambers JT. Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol, 1997,21 (12) :1507-1514.
6Silva EG,Jenkins R. Serous carcinoala in endometrial polyps. Mod Pathol, 1990,3 (2) : 120-128.
7Wheeler DT, Bell KA, Kurman RJ, et al. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol, 2000,24(6) :797-806.
8Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol, 2003,91 (3) :463-469.
9Kupryjanczyk J, Thor AD, Beauchamp R, et al. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. Mod Pathol, 1996,9 ( 3 ) : 166-173.
10Soslow RA, Shen PU, Isacson C, et al. The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype. Mod Pathol, 1998,11 (2) : 194-199.
